Keyphrases
Diabetic Nephropathy
100%
Diabetic Kidney Disease
100%
Adverse Effects
100%
Renin-angiotensin-aldosterone System
100%
Unfulfilled Promises
100%
Dual Blockade
50%
Potential Gains
25%
Type 2 Diabetes Mellitus (T2DM)
25%
Chronic Kidney Disease
25%
Monotherapy
25%
Cardiovascular Outcomes
25%
Proteinuria
25%
Randomized Clinical Trial
25%
Patients with Diabetes
25%
Angiotensin Receptor Blockers
25%
Potential Therapy
25%
Renal Outcome
25%
Renin-angiotensin-aldosterone System Blockade
25%
Major Complications
25%
Diabetes Mellitus Complications
25%
Dual Therapy
25%
End-stage Kidney Disease
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Disease Burden
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Aldosterone
100%
Renin
100%
Angiotensin
100%
Diabetic Nephropathy
100%
Randomized Clinical Trial
20%
Chronic Kidney Failure
20%
Prevalence
20%
End Stage Renal Disease
20%
Angiotensin Receptor Antagonist
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Proteinuria
20%
Disease
20%
Diabetes Mellitus
20%
Monotherapy
20%
Non Insulin Dependent Diabetes Mellitus
20%